Aperture Investors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-287,557
Closed -$13.7M 81
2023
Q3
$13.7M Sell
287,557
-239,609
-45% -$13.1M 2.18% 21
2023
Q2
$30.7M Buy
527,166
+152,168
+41% +$9.13M 3.65% 7
2023
Q1
$26.8M Sell
374,998
-12,712
-3% -$1.01M 3.71% 6
2022
Q4
$27.3M Sell
387,710
-47,099
-11% -$3.32M 4.45% 3
2022
Q3
$26.4M Buy
434,809
+82,001
+23% +$5.5M 4.31% 4
2022
Q2
$22.3M Buy
352,808
+19,385
+6% +$1.26M 3.71% 6
2022
Q1
$21.4M Buy
333,423
+119,764
+56% +$8.01M 2.77% 14
2021
Q4
$15.3M Hold
213,659
1.97% 21
2021
Q3
$15.2M Hold
213,659
2.05% 22
2021
Q2
$17.4M Sell
213,659
-15,602
-7% -$1.25M 1.99% 15
2021
Q1
$17.3M Buy
229,261
+25,367
+12% +$1.85M 2.66% 13
2020
Q4
$15.4M Sell
203,894
-32,734
-14% -$2.13M 2.63% 12
2020
Q3
$11.7M Sell
236,628
-21,028
-8% -$1.19M 2.88% 9
2020
Q2
$13.5M Buy
257,656
+84,124
+48% +$3.99M 3.43% 4
2020
Q1
$6.11M Buy
+173,532
New +$10.1M 2.42% 14

Other funds holding NGVT

Aperture Investors's NGVT Position: Q4 2023 in Review

Aperture Investors sold out of Ingevity (NGVT) in Q4 2023, closing a stake of 287,557 shares — an estimated $13.7M sold.

Aperture Investors first reported a position in NGVT in Q1 2020 and held it in 15 quarters. The position peaked at $30.7M in Q2 2023. 252 funds tracked by Wall St. Rank hold NGVT as of Q4 2023.

  • Aperture Investors reported no remaining Ingevity position as of Q4 2023 after selling out during the quarter.
  • Aperture Investors sold 287,557 Ingevity shares in Q4 2023, an estimated $13.7M.
  • Aperture Investors first reported a position in Ingevity in Q1 2020 and held it in 15 quarters.
  • Aperture Investors's Ingevity position peaked at $30.7M in Q2 2023.
  • 252 funds tracked by Wall St. Rank held Ingevity as of Q4 2023.

Based on Aperture Investors's 13F filing for Q4 2023, filed 14 Feb 2024.